Investigation of Cognitive Impairment in the Course of Post-COVID Syndrome

(1) Background: The study presents results from an investigation of cognitive impairment in patients hospitalized the first psychiatric clinic Bulgaria to treat with COVID-19 during pandemic period between 2020 and 2022. One hundred twenty who had recovered acute infection (up 12 weeks ago) no previous history participated study. In 23 them (19.17%), disturbance functioning was observed. (2) Methods: All underwent neuropsychological (Luria’s test, Platonov’s Maze MMSE, Boston Naming test) neuroimaging examinations. Only seven evidence cortical atrophy on CT/MRI images. most significantly demonstrative image one those is presented. (3) Results: testing both groups show a certain decrease fixation memory retention as well range, concentration, distribution switching attention. Deviations norm Test, were found group (mild moderate aphasia). Neuroprotective agents such Citicoline, Piracetam Memantine prescribed evident atrophy. After 3 months, positive examination reported groups. (4) Conclusions: Although there are limited data benefit prescribing pro-cognitive post-COVID period, our clinical experience suggests that it might be useful recovery process infection’s consequences cognition for brain pathology.